PIVKA-II Is a Useful Tumor Marker for Recurrent Hepatocellular Carcinoma after Surgical Resection

Publisher： Karger

E-ISSN： 1423-0232|72|1|52-57

ISSN： 0030-2414

Source： Oncology, Vol.72, Iss.1, 2007-12, pp. : 52-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PIVKA-II Is the Best Prognostic Predictor in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation Therapy

By  

Oncology, Vol. 75, Iss. 1, 2008-12 ,pp. : 91-98

Karger

Access to resources Recommend Favorite

Laparoscopic liver resection for treating recurrent hepatocellular carcinoma

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 20, Iss. 5, 2013-06 ,pp. : 512-517

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surgical Treatment of Hepatocellular Carcinoma: Comparison of Resection and Transplantation

By  

Oncology, Vol. 75, Iss. 1, 2008-12 ,pp. : 119-123

Karger

Access to resources Recommend Favorite

Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 7, 2015-07 ,pp. : 961-968

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 4, 2015-04 ,pp. : 404-409

John Wiley & Sons Inc

Access to resources Recommend Favorite